Skip to content

Clinical trials

Splenomegaly trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Splenomegaly Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20071
20081
20102
20121
20133
20142
20153
20162
20174
20183
20192
20203
20212
20232
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting6
Unknown status5
Terminated5
Withdrawn3
Not yet recruiting2
Active, not recruiting2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
CENTOGENE GmbH Rostock3
CTI BioPharma2
Fundación Española de Hematología y Hemoterapía2
National Institute of Allergy and Infectious Diseases (NIAID)2
Sanofi2
Shanghai Zhongshan Hospital2
University of British Columbia2
AbbVie1
Brigham and Women's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Splenomegaly41
Primary Myelofibrosis9
Anemia7
Gaucher Disease6
Hepatomegaly6
Lymphadenopathy5
Thrombocytopenia5
Bone Marrow Diseases4
Hematologic Diseases4
Hypertension, Portal4

Trials

Showing 26 to 41 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.